Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Tianjin Tianyao Pharmaceuticals Co., Ltd.

Why is Tianjin Tianyao Pharmaceuticals Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 4.51%

The company has been able to generate a Return on Capital Employed (avg) of 4.51% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of -0.13% and Operating profit at -8.32% over the last 5 years

With a fall in PBT of -16.45%, the company declared Very Negative results in Sep 25

The company has declared negative results for the last 2 consecutive quarters
The company has declared negative results in Dec 24 after 2 consecutive negative quarters
NET PROFIT(HY) At CNY 11.49 MM has Grown at -91.07%
OPERATING CASH FLOW(Y) Lowest at CNY 150.11 MM
ROCE(HY) Lowest at 0.54%

With ROE of 3.83%, it has a expensive valuation with a 1.48 Price to Book Value

Over the past year, while the stock has generated a return of -2.81%, its profits have fallen by -37.5%
At the current price, the company has a high dividend yield of 2.4

Below par performance in long term as well as near term

Along with generating -2.81% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Tianjin Tianyao Pharmaceuticals Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Tianjin Tianyao Pharmaceuticals Co., Ltd.

-12.78%

0.51

21.30%

China Shanghai Composite

13.33%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-0.13%

EBIT Growth (5y)

-8.32%

EBIT to Interest (avg)

4.55

Debt to EBITDA (avg)

1.82

Net Debt to Equity (avg)

0.02

Sales to Capital Employed (avg)

0.86

Tax Ratio

6.47%

Dividend Payout Ratio

80.20%

Pledged Shares

Institutional Holding

ROCE (avg)

4.51%

ROE (avg)

3.94%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.48

EV to EBIT

24.41

EV to EBITDA

9.32

EV to Capital Employed

1.45

EV to Sales

1.55

PEG Ratio

Dividend Yield

2.42%

ROCE (Latest)

5.95%

ROE (Latest)

3.83%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -5.05% (YoY

NET PROFIT(Q)

At CNY 20.24 MM has Grown at 98.71%

-24What is not working for the Company

NET PROFIT(HY)

At CNY 11.49 MM has Grown at -91.07%

OPERATING CASH FLOW(Y)

Lowest at CNY 150.11 MM

ROCE(HY)

Lowest at 0.54%

NET SALES(Q)

At CNY 643.16 MM has Fallen at -13.76%

INTEREST COVERAGE RATIO(Q)

Lowest at 536.41

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.74 times

OPERATING PROFIT(Q)

Lowest at CNY 27.03 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 4.2 %

Here's what is working for Tianjin Tianyao Pharmaceuticals Co., Ltd.

Net Profit

At CNY 20.24 MM has Grown at 98.71%

over average net sales of the previous four periods of CNY 10.18 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Raw Material Cost

Fallen by -5.05% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Tianjin Tianyao Pharmaceuticals Co., Ltd.

Net Sales

At CNY 643.16 MM has Fallen at -13.76%

over average net sales of the previous four periods of CNY 745.77 MM

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Interest Coverage Ratio

Lowest at 536.41

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Cash Flow

Lowest at CNY 150.11 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Profit

Lowest at CNY 27.03 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 4.2 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Debtors Turnover Ratio

Lowest at 4.74 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio